Market Share of Global Metastatic Melanoma Drugs Industry
The metastatic melanoma drugs market is fragmented in nature due to the presence of several companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies which hold the market shares and are well known. include Bristol-Myers Squibb Company, Novartis AG, Merck & Co., Inc., F. Hoffmann-La Roche Ltd, Amgen, Inc., AstraZeneca, Pfizer Inc., Sanofi, Accord Healthcare, and Amneal Pharmaceuticals LLC., among others.
Metastatic Melanoma Drugs Market Leaders
Bristol-Myers Squibb Company
Pfizer Inc.
Novartis AG
Merck & Co., Inc.
F. Hoffmann-La Roche Ltd
*Disclaimer: Major Players sorted in no particular order
